Mefpas 500mg Tablet

Adults and adolescents 14 years of age and older: 500 mg given orally as an initial dose followed by 250 mg every 6 hours as needed For the treatment of primary dysmenorrhea: 500 mg given orally as an initial dose followed by 250 mg every 6 hours 2.1 Important Dosage and Administration Information Carefully consider the potential benefits and risks of mefenamic acid capsules and other treatment options before deciding to use mefenamic acid capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

Directions from the U.S. FDA-approved label for Mefenamic Acid — your doctor or pharmacist may advise differently.

Mefenamic acid is contraindicated in the following patients: Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to mefenamic acid or any components of the drug product. History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients. In the setting of coronary artery bypass graft (CABG) surgery.

Excerpt from the U.S. FDA-approved label for Mefenamic Acid. Talk to a pharmacist or doctor before use.

Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests persist or worsen or if clinical signs and symptoms of liver disease develop. Hypertension: Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs. Monitor blood pressure. Heart Failure and Edema: Avoid use of mefenamic acid in patients with severe heart failure unless benefits are expected to outweigh risk of worsening heart failure.

Warnings and precautions excerpt from the U.S. FDA-approved label for Mefenamic Acid — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are discussed in greater detail in other sections of the labeling: Cardiovascular Thrombotic Events GI Bleeding, Ulceration and Perforation Hepatotoxicity Hypertension Heart Failure and Edema Renal Toxicity and Hyperkalemia Anaphylactic Reactions Serious Skin Reactions Hematologic Toxicity Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in…

Excerpt from the U.S. FDA-approved label for Mefenamic Acid — not a complete list. Talk to a pharmacist or doctor about side effects.

8 brands · 4 makers in the NepalDoc catalog — see the full Mefenamic Acid guide →

Store at 20° to 25°C (68° to 77°F);

Storage information from the U.S. FDA-approved label for Mefenamic Acid.